Karsch, K.

patient thrombocytopenia intervention study baseline group platelet eptifibatide trial percutaneou event treatment 30 days placebo outcome investigator pursuit month infarction heart population effect death model /iiia artery angina disease measurement function perindopril complication table difference syndrome glycoprotein artery disease incidence nonfatal mi result therapy elevation ace inhibition characteristic baseline characteristics swets subs service 6 months receptor procedure brachial artery timing inhibition nadir heparin count 0.001 heart failure pursuit trial day 1 analysis change benefit revascularization value reduction brachial end point point nadir platelet count circulation coll cardiol angiography ͻ0.001 angiotensin nonfatal finding st-segment elevation eur heart j mortality blocker